Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | %Female (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Diabetes Reviews | journal | 0.765 Q2 | 68 | 105 | 306 | 8047 | 991 | 300 | 2.27 | 76.64 | 50.64 | |
2 | Current Medicinal Chemistry | journal | 0.759 Q2 | 202 | 229 | 1117 | 25841 | 4143 | 1046 | 3.54 | 112.84 | 45.47 | |
3 | Current Drug Targets | journal | 0.691 Q2 | 119 | 97 | 390 | 10001 | 1214 | 368 | 2.96 | 103.10 | 43.82 | |
4 | Current Gene Therapy | journal | 0.674 Q3 | 80 | 33 | 114 | 3190 | 359 | 106 | 3.41 | 96.67 | 40.14 | |
5 | Current Cancer Drug Targets | journal | 0.650 Q3 | 103 | 76 | 216 | 5127 | 602 | 211 | 2.34 | 67.46 | 40.55 | |
6 | Mini-Reviews in Medicinal Chemistry | journal | 0.597 Q3 | 107 | 128 | 492 | 14236 | 1903 | 484 | 3.60 | 111.22 | 43.35 | |
7 | Current Genomics | journal | 0.543 Q3 | 77 | 33 | 152 | 1866 | 381 | 135 | 1.91 | 56.55 | 44.36 | |
8 | Current Molecular Pharmacology | journal | 0.540 Q3 | 49 | 72 | 209 | 6446 | 509 | 199 | 2.37 | 89.53 | 43.73 | |
9 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.540 Q3 | 52 | 41 | 103 | 3859 | 252 | 100 | 2.51 | 94.12 | 48.44 | |
10 | Current Protein and Peptide Science | journal | 0.527 Q3 | 96 | 69 | 252 | 5886 | 615 | 237 | 1.95 | 85.30 | 41.45 | |
11 | Current Aging Science | journal | 0.505 Q4 | 42 | 28 | 75 | 1742 | 180 | 72 | 1.82 | 62.21 | 46.67 | |
12 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.503 Q3 | 108 | 201 | 723 | 12531 | 2011 | 702 | 2.69 | 62.34 | 40.91 | |
13 | Current Bioinformatics | journal | 0.383 Q3 | 38 | 66 | 321 | 3915 | 733 | 315 | 2.41 | 59.32 | 31.63 | |
14 | Infectious Disorders - Drug Targets | journal | 0.338 Q4 | 61 | 89 | 374 | 4320 | 542 | 350 | 1.47 | 48.54 | 42.90 | |
15 | Current Organic Synthesis | journal | 0.318 Q3 | 55 | 51 | 184 | 3705 | 355 | 159 | 1.93 | 72.65 | 37.80 | |
16 | Open Medicinal Chemistry Journal | journal | 0.289 Q4 | 23 | 9 | 22 | 476 | 47 | 19 | 2.80 | 52.89 | 36.36 | |
17 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.283 Q4 | 39 | 22 | 60 | 1112 | 86 | 57 | 1.45 | 50.55 | 48.61 | |
18 | Current Computer-Aided Drug Design | journal | 0.283 Q4 | 32 | 36 | 197 | 1766 | 365 | 191 | 1.76 | 49.06 | 38.22 | |
19 | Recent Patents on Biotechnology | journal | 0.277 Q3 | 42 | 26 | 75 | 2019 | 117 | 70 | 1.29 | 77.65 | 44.33 | |
20 | Current Nanoscience | journal | 0.267 Q3 | 52 | 74 | 228 | 5777 | 388 | 221 | 1.65 | 78.07 | 41.03 | |
21 | Open Biotechnology Journal | journal | 0.264 Q3 | 18 | 16 | 40 | 793 | 72 | 38 | 1.75 | 49.56 | 39.62 | |
22 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.258 Q4 | 45 | 31 | 108 | 1193 | 98 | 103 | 0.85 | 38.48 | 37.50 | |
23 | Letters in Drug Design and Discovery | journal | 0.222 Q4 | 37 | 172 | 329 | 9716 | 360 | 304 | 1.23 | 56.49 | 39.72 | |
24 | Current Chemical Biology | journal | 0.202 Q4 | 26 | 23 | 65 | 1482 | 50 | 61 | 0.62 | 64.43 | 50.00 | |
25 | Current Signal Transduction Therapy | journal | 0.188 Q4 | 22 | 20 | 80 | 940 | 47 | 71 | 0.58 | 47.00 | 36.51 | |
26 | Current Pharmaceutical Analysis | journal | 0.184 Q4 | 27 | 63 | 339 | 3875 | 249 | 329 | 0.77 | 61.51 | 54.03 | |
27 | Drug Metabolism Letters | journal | 0.175 Q4 | 31 | 0 | 24 | 0 | 25 | 23 | 1.04 | 0.00 | 0.00 | |
28 | Letters in Organic Chemistry | journal | 0.174 Q4 | 33 | 123 | 375 | 5692 | 266 | 336 | 0.76 | 46.28 | 39.94 | |
29 | Current Cancer Therapy Reviews | journal | 0.172 Q4 | 17 | 30 | 100 | 2663 | 61 | 93 | 0.44 | 88.77 | 42.97 | |
30 | Current Proteomics | journal | 0.162 Q4 | 27 | 21 | 143 | 996 | 74 | 138 | 0.52 | 47.43 | 46.30 | |
31 | Current Enzyme Inhibition | journal | 0.157 Q4 | 19 | 25 | 71 | 1315 | 56 | 64 | 0.85 | 52.60 | 39.24 | |
32 | Open Biomarkers Journal | journal | 0.143 Q4 | 7 | 3 | 34 | 108 | 8 | 34 | 0.12 | 36.00 | 33.33 | |
33 | Current Pharmacogenomics and Personalized Medicine | journal | 0.127 Q4 | 20 | 12 | 49 | 613 | 9 | 42 | 0.08 | 51.08 | 54.55 | |
34 | Frontiers in Natural Product Chemistry | book series | 0.111 Q4 | 3 | 1 | 36 | 0 | 6 | 5 | 0.19 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®